MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma
Abstract Retinoblastoma is a rare, intraocular paediatric cancer that originates in the neural retina and is most frequently caused by bi-allelic loss of RB1 gene function. Other oncogenic mutations, such as amplification and increased expression of the MYCN gene, have been found even with proficien...
Main Authors: | Maria K. E. Blixt, Minas Hellsand, Dardan Konjusha, Hanzhao Zhang, Sonya Stenfelt, Mikael Åkesson, Nima Rafati, Tatsiana Tararuk, Gustav Stålhammar, Charlotta All-Eriksson, Henrik Ring, Finn Hallböök |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-06-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-022-00409-3 |
Similar Items
-
Heterogeneity in retinoblastoma: a tale of molecules and models
by: Sonya Stenfelt, et al.
Published: (2017-11-01) -
Endothelin B Receptors on Primary Chicken Müller Cells and the Human MIO-M1 Müller Cell Line Activate ERK Signaling via Transactivation of Epidermal Growth Factor Receptors.
by: Mohammad Harun-Or-Rashid, et al.
Published: (2016-01-01) -
High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures
by: Khashayar Roohollahi, MSc, et al.
Published: (2022-09-01) -
Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression
by: Pamorn Chittavanich, et al.
Published: (2024-04-01) -
The Oncogene <i>MYCN</i> Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma
by: Swatishree Sradhanjali, et al.
Published: (2021-10-01)